出海BD驱动创新药板块再启航,投资机会在哪里?

国金证券股份有...
Feb 11

近日,A股、港股创新药板块集体发力、强势拉升!板块内多只个股逆势走高,恒生港股通创新药精选指数虽有震荡分化,但核心标的表现亮眼,港股创新药ETF更连续多日获得资金净流入,市场对该板块的关注度持续升温。中国创新药在经历了集采阵痛、出海波折与资本寒潮,以及2025年前三季度的大幅上涨后,板块是否仍有潜力?国金证券医药行业首席分析师甘坛焕认为,创新药企业扭亏节点到来,全年临床数据催化密集,叠加已BD出海...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10